← All news
Earnings
Danish Central Bank Doubles Growth Forecast on Novo’s US Boom
2 outlets - including Fortune and Bloomberg - are covering this story. "The growth is mainly due to Novo’s sales and production in the U.S. market at the beginning of this year."
Covered by 2 outlets
All coverage · 2 articles
Fortune
·Sep 23, 11:09 UTC
U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast
"The growth is mainly due to Novo’s sales and production in the U.S. market at the beginning of this year."
Bloomberg Economics
·Sep 23, 07:04 UTC
Danish Central Bank Doubles Growth Forecast on Novo’s US Boom
Denmark’s central bank more than doubled its growth forecast for this year as surging US sales and production at Novo Nordisk A/S fuel strong exports in the Nordic country’s pharmaceutical industry.